Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | cytochrome P450, family 3, subfamily A, polypeptide 4 | Starlite/ChEMBL | References |
Homo sapiens | MET proto-oncogene, receptor tyrosine kinase | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | cytochrome P450 | cytochrome P450, family 3, subfamily A, polypeptide 4 | 502 aa | 492 aa | 24.2 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Carboxylesterase family protein | 0.0257 | 0.1631 | 0.1608 |
Onchocerca volvulus | 0.0257 | 0.1631 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.0257 | 0.1631 | 0.1631 |
Loa Loa (eye worm) | CYP4Cod1 | 0.0015 | 0.0028 | 0.0028 |
Brugia malayi | Carboxylesterase family protein | 0.0257 | 0.1631 | 0.1608 |
Echinococcus granulosus | BC026374 protein S09 family | 0.0257 | 0.1631 | 0.1552 |
Schistosoma mansoni | neuroligin 3 (S09 family) | 0.0257 | 0.1631 | 0.1623 |
Echinococcus multilocularis | carboxylesterase 5A | 0.1519 | 1 | 1 |
Brugia malayi | plexin A | 0.0025 | 0.0093 | 0.0065 |
Loa Loa (eye worm) | hypothetical protein | 0.0257 | 0.1631 | 0.1631 |
Schistosoma mansoni | plexin | 0.0021 | 0.0068 | 0.0058 |
Brugia malayi | Carboxylesterase family protein | 0.0257 | 0.1631 | 0.1608 |
Schistosoma mansoni | BC026374 protein (S09 family) | 0.0257 | 0.1631 | 0.1623 |
Echinococcus multilocularis | BC026374 protein (S09 family) | 0.0257 | 0.1631 | 0.1552 |
Loa Loa (eye worm) | hypothetical protein | 0.0012 | 0.001 | 0.001 |
Mycobacterium tuberculosis | POSSIBLE PARA-NITROBENZYL ESTERASE (FRAGMENT) | 0.0257 | 0.1631 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.1519 | 1 | 1 |
Echinococcus granulosus | family S9 non peptidase ue S09 family | 0.0257 | 0.1631 | 0.1552 |
Echinococcus granulosus | acetylcholinesterase | 0.1519 | 1 | 1 |
Schistosoma mansoni | gliotactin | 0.0257 | 0.1631 | 0.1623 |
Echinococcus granulosus | carboxylesterase 5A | 0.1519 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0257 | 0.1631 | 0.1631 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.0257 | 0.1631 | 0.1623 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0015 | 0.0028 | 0.0028 |
Trypanosoma cruzi | cytochrome P450, putative | 0.0015 | 0.0028 | 0.5 |
Brugia malayi | Carboxylesterase family protein | 0.1519 | 1 | 1 |
Mycobacterium tuberculosis | POSSIBLE PARA-NITROBENZYL ESTERASE (FRAGMENT) | 0.0257 | 0.1631 | 0.5 |
Trichomonas vaginalis | spcc417.12 protein, putative | 0.0257 | 0.1631 | 0.5 |
Echinococcus multilocularis | acetylcholinesterase | 0.1519 | 1 | 1 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.0257 | 0.1631 | 0.1623 |
Loa Loa (eye worm) | hypothetical protein | 0.0257 | 0.1631 | 0.1631 |
Echinococcus multilocularis | family S9 non peptidase ue (S09 family) | 0.0257 | 0.1631 | 0.1552 |
Mycobacterium tuberculosis | Carboxylesterase LipT | 0.0257 | 0.1631 | 0.5 |
Leishmania major | cytochrome p450-like protein | 0.0015 | 0.0028 | 0.5 |
Echinococcus granulosus | neuroligin | 0.0257 | 0.1631 | 0.1552 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0015 | 0.0028 | 0.0028 |
Mycobacterium ulcerans | carboxylesterase, LipT | 0.0257 | 0.1631 | 1 |
Echinococcus granulosus | para nitrobenzyl esterase | 0.0257 | 0.1631 | 0.1552 |
Onchocerca volvulus | 0.0257 | 0.1631 | 1 | |
Brugia malayi | Carboxylesterase family protein | 0.0257 | 0.1631 | 0.1608 |
Loa Loa (eye worm) | carboxylesterase | 0.0257 | 0.1631 | 0.1631 |
Loa Loa (eye worm) | hypothetical protein | 0.0257 | 0.1631 | 0.1631 |
Trypanosoma cruzi | cytochrome P450, putative | 0.0015 | 0.0028 | 0.5 |
Brugia malayi | hypothetical protein | 0.0257 | 0.1631 | 0.1608 |
Brugia malayi | Plexin repeat family protein | 0.0021 | 0.0068 | 0.004 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.1519 | 1 | 1 |
Echinococcus multilocularis | acetylcholinesterase | 0.1519 | 1 | 1 |
Onchocerca volvulus | 0.0257 | 0.1631 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.0068 | 0.0068 |
Echinococcus multilocularis | neuroligin | 0.0257 | 0.1631 | 0.1552 |
Loa Loa (eye worm) | hypothetical protein | 0.1519 | 1 | 1 |
Onchocerca volvulus | 0.0257 | 0.1631 | 1 | |
Loa Loa (eye worm) | acetylcholinesterase 1 | 0.1519 | 1 | 1 |
Echinococcus multilocularis | para nitrobenzyl esterase | 0.0257 | 0.1631 | 0.1552 |
Trypanosoma brucei | cytochrome P450, putative | 0.0015 | 0.0028 | 0.5 |
Loa Loa (eye worm) | carboxylesterase | 0.1519 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0257 | 0.1631 | 0.1631 |
Schistosoma mansoni | acetylcholinesterase | 0.0257 | 0.1631 | 0.1623 |
Echinococcus granulosus | acetylcholinesterase | 0.1519 | 1 | 1 |
Loa Loa (eye worm) | plexin A | 0.0025 | 0.0093 | 0.0093 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.0257 | 0.1631 | 0.1623 |
Trichomonas vaginalis | carboxylesterase domain containing protein, putative | 0.0257 | 0.1631 | 0.5 |
Onchocerca volvulus | 0.0257 | 0.1631 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.0257 | 0.1631 | 0.1631 |
Loa Loa (eye worm) | carboxylesterase | 0.0257 | 0.1631 | 0.1631 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 5 nM | Inhibition of c-Met by HTRF assay | ChEMBL. | 19819693 |
IC50 (binding) | = 7 nM | Inhibition of HGF-mediated human c-Met autophosphorylation expressed in human PC3 cells after 1 hr by electrochemiluminescent immunoassay | ChEMBL. | 19819693 |
IC50 (ADMET) | = 16 uM | Inhibition of human CYP3A4 in human liver microsomes preincubated with NADPH | ChEMBL. | 19819693 |
IC50 (ADMET) | > 50 uM | Inhibition of human CYP3A4 | ChEMBL. | 19819693 |
Ki (binding) | = 2.7 nM | BindingDB_Patents: In Vitro Assay. A PCR product covering residues 1058-1365 of c-Met (c-Met kinase domain) is generated from Human Liver QuickClone cDNA (Invitrogen) using forward primer 5'-ATTGACGGATCCATGCTAAATCCAGAGCTGGTCCAGGCA-3' (SEQ ID NO. 1) and reverse primer 5'-ACAACAGAATTCAATACGGAGCGACACATTTTACGTT-3' (SEQ ID NO. 2). The PCR product is cloned into a modified pFastBac 1 expression vector (harboring the gene for S. japonicum glutathione S-transferase immediately upstream of the multiple cloning site) using standard molecular biological techniques. The GST-c-Met kinase domain fusion (GST-Met) gene is transposed into full-length baculovirus DNA using the BacToBac system (Invitrogen). High5 cells are infected with the recombinant baculovirus for 72 h at 27 C. The infected cells are harvested by centrifugation and the pellet is stored at -80 C. The pellet is resuspended in buffer A (50 mM HEPES, pH 8.0, 0.25 M NaCl, 10 mM 2-mercaptoethanol, 10% (w/v) glycerol, 0.5% (v/v) protease. | ChEMBL. | No reference |
Ki (binding) | = 2.7 nM | BindingDB_Patents: In Vitro Assay. A PCR product covering residues 1058-1365 of c-Met (c-Met kinase domain) is generated from Human Liver QuickClone cDNA (Invitrogen) using forward primer 5'-ATTGACGGATCCATGCTAAATCCAGAGCTGGTCCAGGCA-3' (SEQ ID NO. 1) and reverse primer 5'-ACAACAGAATTCAATACGGAGCGACACATTTTACGTT-3' (SEQ ID NO. 2). The PCR product is cloned into a modified pFastBac 1 expression vector (harboring the gene for S. japonicum glutathione S-transferase immediately upstream of the multiple cloning site) using standard molecular biological techniques. The GST-c-Met kinase domain fusion (GST-Met) gene is transposed into full-length baculovirus DNA using the BacToBac system (Invitrogen). High5 cells are infected with the recombinant baculovirus for 72 h at 27 C. The infected cells are harvested by centrifugation and the pellet is stored at -80 C. The pellet is resuspended in buffer A (50 mM HEPES, pH 8.0, 0.25 M NaCl, 10 mM 2-mercaptoethanol, 10% (w/v) glycerol, 0.5% (v/v) protease. | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.